Literature DB >> 19332258

The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis.

David Shitrit1, Victorya Rusanov, Nir Peled, Anat Amital, Leonardo Fuks, Mordechai R Kramer.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with a median survival of approximately 3 years. Measurements of lung volumes and diffusion capacity at rest are generally used to monitor the clinical course of IPF. Due to its high mortality, identification of patients at high risk is crucial for treatment strategies such as lung transplantation. This study was design to determine whether the simple 15-step climbing exercise oximetry test accurately characterizes disease severity and survival in patients with IPF.
METHODS: The study population consisted of 51 patients with progressive IPF. Findings on the 15-step climbing test, pulmonary function tests, cardiopulmonary exercise test and 6-minute walk distance test were assessed at baseline. Participants were prospectively followed for >or=2 years to determine the relationship between the test parameters and survival.
RESULTS: On univariate analysis, there were strong correlations between the 15-stair climbing test parameters and survival. On stepwise linear regression analysis, independent significant predictors of mortality were lowest saturation levels on the 15-step test and the 6-minute walk distance test.
CONCLUSIONS: The lowest saturation and desaturation areas on the 15-step oximetry test are significantly associated with long-term outcome in patients with IPF. We suggest that the 15-step test be used as a simple and reliable tool to predict severity and prognosis in IPF and to identify candidates for lung transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19332258     DOI: 10.1016/j.healun.2008.12.019

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

Review 2.  Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature.

Authors:  Kristin D Kistler; Luba Nalysnyk; Philip Rotella; Dirk Esser
Journal:  BMC Pulm Med       Date:  2014-08-16       Impact factor: 3.317

Review 3.  Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible.

Authors:  Elisabetta Balestro; Elisabetta Cocconcelli; Mariaenrica Tinè; Davide Biondini; Eleonora Faccioli; Marina Saetta; Federico Rea
Journal:  Medicina (Kaunas)       Date:  2019-10-19       Impact factor: 2.430

4.  Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.

Authors:  Steve Goodacre; Ben Thomas; Ellen Lee; Laura Sutton; Amanda Loban; Simon Waterhouse; Richard Simmonds; Katie Biggs; Carl Marincowitz; José Schutter; Sarah Connelly; Elena Sheldon; Jamie Hall; Emma Young; Andrew Bentley; Kirsty Challen; Chris Fitzsimmons; Tim Harris; Fiona Lecky; Andrew Lee; Ian Maconochie; Darren Walter
Journal:  Emerg Med J       Date:  2020-12-03       Impact factor: 2.740

Review 5.  Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: A rapid review.

Authors:  Anne E Holland; Carla Malaguti; Mariana Hoffman; Aroub Lahham; Angela T Burge; Leona Dowman; Anthony K May; Janet Bondarenko; Marnie Graco; Gabriella Tikellis; Joanna Yt Lee; Narelle S Cox
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.